Compounded Tranexamic Acid (TXA) 7.5% Topical Gel in BASSAGEL® 7.5% — Compounded Topical Gel Patient Monograph
Patient education monograph for Compounded Tranexamic Acid (TXA) 7.5% Topical Gel in BASSAGEL® (7.5%), a compounded topical gel. Learn how it works, how to use it, possible side effects, and find a licensed compounding pharmacy near you.
What is Compounded Tranexamic Acid (TXA) 7.5% Topical Gel in BASSAGEL®?
This compounded preparation contains tranexamic acid 7.5% in a BASSAGEL® topical gel base, prepared by a licensed compounding pharmacy pursuant to an individual patient prescription. It is designed for topical use to support localized minor bleeding control when prescribed by a healthcare provider. BASSAGEL® is a specialized topical gel base selected for its excellent skin adhesion and uniform drug delivery at the application site. Formula developed in partnership with Richie's Specialty Pharmacy.
How does Compounded Tranexamic Acid (TXA) 7.5% Topical Gel in BASSAGEL® work?
Tranexamic acid is a synthetic lysine analogue that acts as an antifibrinolytic agent. It works by competitively inhibiting plasminogen activation, which blocks the conversion of plasminogen to plasmin — the enzyme responsible for breaking down fibrin clots. By stabilizing fibrin clot structure at the site of application, tranexamic acid supports the body's natural hemostatic response and helps prevent premature dissolution of blood clots that form to stop minor localized bleeding. Topical application in the BASSAGEL® base delivers the active agent directly to the bleeding site with minimal sy
How to use Compounded Tranexamic Acid (TXA) 7.5% Topical Gel in BASSAGEL®
Use exactly as directed by your healthcare provider. Wash and dry hands thoroughly before application. Apply a thin, even layer of gel to the affected area. Use only the amount your provider has instructed. Avoid rubbing aggressively — gentle application is sufficient. Wash hands after application unless the hands are the area being treated. Do not apply to large open wounds or extensive skin areas without specific prescriber direction.
Compounded Tranexamic Acid (TXA) 7.5% Topical Gel in BASSAGEL® side effects
Topically applied tranexamic acid in BASSAGEL® is generally well tolerated. Some patients may experience mild irritation, transient redness, temporary burning sensation, or dryness at the application site. These effects are typically minor. Stop use and contact your prescriber promptly if you notice severe irritation, rash, swelling, hives, difficulty breathing, or worsening bleeding.
Drug interactions with Compounded Tranexamic Acid (TXA) 7.5% Topical Gel in BASSAGEL®
Systemic absorption from topical application is minimal; significant drug interactions are unlikely with localized use. Do not apply to eyes, mouth, or mucous membranes unless specifically prescribed for those sites. Avoid concurrent use on large open wounds without prescriber guidance. Inform your prescriber of all current medications, particularly anticoagulants or blood-thinning agents, before using this preparation.
How to store Compounded Tranexamic Acid (TXA) 7.5% Topical Gel in BASSAGEL®
Store at room temperature, 59°F–77°F (15°C–25°C). Keep container tightly closed. Protect from heat and moisture. Keep out of reach of children and pets. Do not use after the beyond-use date printed on the pharmacy label.
Precautions for Compounded Tranexamic Acid (TXA) 7.5% Topical Gel in BASSAGEL®
For external use only. Do not swallow. Do not apply to large open wounds, deep lacerations, or extensive skin injuries without specific prescriber instruction. Inform your prescriber if you have a history of blood clots, thromboembolic disease, or clotting disorders, or if you are pregnant or breastfeeding. Patients taking anticoagulants or blood thinners should discuss use with their prescriber b
Frequently Asked Questions — Compounded Tranexamic Acid (TXA) 7.5% Topical Gel in BASSAGEL®
- What is Compounded Tranexamic Acid (TXA) 7.5% Topical Gel in BASSAGEL®?
- This compounded preparation contains tranexamic acid 7.5% in a BASSAGEL® topical gel base, prepared by a licensed compounding pharmacy pursuant to an individual patient prescription. It is designed for topical use to support localized minor bleeding control when prescribed by a healthcare provider. BASSAGEL® is a specialized topical gel base selected for its excellent skin adhesion and uniform drug delivery at the application site. Formula developed in partnership with Richie's Specialty Pharmac
- How does Compounded Tranexamic Acid (TXA) 7.5% Topical Gel in BASSAGEL® work?
- Tranexamic acid is a synthetic lysine analogue that acts as an antifibrinolytic agent. It works by competitively inhibiting plasminogen activation, which blocks the conversion of plasminogen to plasmin — the enzyme responsible for breaking down fibrin clots. By stabilizing fibrin clot structure at the site of application, tranexamic acid supports the body's natural hemostatic response and helps prevent premature dissolution of blood clots that form to stop minor localized bleeding. Topical appli
- How do I use Compounded Tranexamic Acid (TXA) 7.5% Topical Gel in BASSAGEL®?
- Use exactly as directed by your healthcare provider. Wash and dry hands thoroughly before application. Apply a thin, even layer of gel to the affected area. Use only the amount your provider has instructed. Avoid rubbing aggressively — gentle application is sufficient. Wash hands after application unless the hands are the area being treated. Do not apply to large open wounds or extensive skin areas without specific prescriber direction.
- What are the side effects of Compounded Tranexamic Acid (TXA) 7.5% Topical Gel in BASSAGEL®?
- Topically applied tranexamic acid in BASSAGEL® is generally well tolerated. Some patients may experience mild irritation, transient redness, temporary burning sensation, or dryness at the application site. These effects are typically minor. Stop use and contact your prescriber promptly if you notice severe irritation, rash, swelling, hives, difficulty breathing, or worsening bleeding.
- Are there drug interactions with Compounded Tranexamic Acid (TXA) 7.5% Topical Gel in BASSAGEL®?
- Systemic absorption from topical application is minimal; significant drug interactions are unlikely with localized use. Do not apply to eyes, mouth, or mucous membranes unless specifically prescribed for those sites. Avoid concurrent use on large open wounds without prescriber guidance. Inform your prescriber of all current medications, particularly anticoagulants or blood-thinning agents, before using this preparation.
- How should I store Compounded Tranexamic Acid (TXA) 7.5% Topical Gel in BASSAGEL®?
- Store at room temperature, 59°F–77°F (15°C–25°C). Keep container tightly closed. Protect from heat and moisture. Keep out of reach of children and pets. Do not use after the beyond-use date printed on the pharmacy label.
- What precautions should I know about Compounded Tranexamic Acid (TXA) 7.5% Topical Gel in BASSAGEL®?
- For external use only. Do not swallow. Do not apply to large open wounds, deep lacerations, or extensive skin injuries without specific prescriber instruction. Inform your prescriber if you have a history of blood clots, thromboembolic disease, or clotting disorders, or if you are pregnant or breastfeeding. Patients taking anticoagulants or blood thinners should discuss use with their prescriber b
- Where can I get compounded Compounded Tranexamic Acid (TXA) 7.5% Topical Gel in BASSAGEL®?
- Compounded Tranexamic Acid (TXA) 7.5% Topical Gel in BASSAGEL® is available through licensed compounding pharmacies on the SlimionRX network. Visit slimionrx.com to find a pharmacy near you.